首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   121篇
  免费   3篇
基础医学   4篇
口腔科学   18篇
临床医学   4篇
内科学   74篇
神经病学   3篇
外科学   12篇
一般理论   1篇
预防医学   3篇
药学   1篇
肿瘤学   4篇
  2022年   1篇
  2021年   2篇
  2020年   2篇
  2017年   1篇
  2016年   4篇
  2015年   5篇
  2014年   6篇
  2013年   2篇
  2009年   1篇
  2008年   1篇
  2007年   1篇
  2006年   3篇
  2005年   1篇
  2004年   1篇
  2001年   1篇
  1999年   1篇
  1997年   1篇
  1994年   1篇
  1991年   1篇
  1990年   1篇
  1989年   2篇
  1988年   1篇
  1987年   1篇
  1986年   3篇
  1985年   4篇
  1982年   1篇
  1978年   2篇
  1977年   1篇
  1976年   2篇
  1975年   1篇
  1974年   1篇
  1970年   1篇
  1963年   1篇
  1941年   1篇
  1940年   6篇
  1939年   14篇
  1936年   10篇
  1934年   1篇
  1932年   11篇
  1931年   16篇
  1930年   7篇
排序方式: 共有124条查询结果,搜索用时 156 毫秒
21.
22.
23.
24.
25.

OBJECTIVE:

Lymphangioleiomyomatosis (LAM) is a rare disease that is currently considered a low-grade neoplasm with metastatic potential and variable progression. Mammalian target of rapamycin (mTOR) inhibitors, such as sirolimus and everolimus, have recently become a treatment option for LAM patients, especially those with extrapulmonary manifestations. The objective of the present study was to describe a case series of four patients with LAM in Brazil who showed significant improvement, particularly in their extrapulmonary manifestations, after treatment with sirolimus (at 1-4 mg/day).

METHODS:

We describe four cases of LAM patients with different extrapulmonary manifestations who were treated with sirolimus.

RESULTS:

After treatment with sirolimus for 12 months, one patient presented resolution of severe chylothorax; one had a significant reduction in renal angiomyolipoma volume; and one showed significant regression of retroperitoneal lymphangioleiomyomas and abdominal lymph node enlargement. After treatment with sirolimus for 6 months, the remaining patient had a significant reduction in the volume of a massive retroperitoneal lymphangioleiomyoma.

CONCLUSIONS:

Our findings confirm that mTOR inhibitors are beneficial for patients with LAM, especially those with extrapulmonary manifestations, such as renal angiomyolipoma, lymphangioleiomyomas, and chylous effusions. However, certain aspects, such as the optimal dose, duration of treatment, and long-term adverse effects, have yet to be sufficiently clarified for mTOR inhibitors to be incorporated into LAM management protocols.  相似文献   
26.
Reizwirkungen     
Ohne Zusammenfassung  相似文献   
27.
28.
This work aimed at comparing the accuracy of the psychiatric diagnoses made under indirect supervision to the diagnoses obtained through Structured Clinical Interview for DSM-III-R (SCID). The study was conducted in 3 university services (outpatient, inpatient and emergency). Data from the emergency service were collected 3 years later, after changes in the training process of the medical staff in psychiatric diagnosis. The sensitivity for Major Depression (outpatient 10.0%; inpatients 60.0%, emergency 90.0%) and Schizophrenia (44.4%; 55.0%; 80.0%) improved over time. The reliability was poor in the outpatient service (Kw = 0.18), and at admission to the inpatient service (Kw = 0.38). The diagnosis elaborated in the discharge of the inpatient service (Kw = 0.55) and in the emergency service (Kw = 0.63) was good. Systematic training of supervisors and residents in operational diagnostic criteria increased the accuracy of psychiatric diagnoses elaborated under indirect supervision, although excellent reliability was not achieved.  相似文献   
29.
A long-term investigation of 20 juvenile patients indicated a great seasonal and interdiurnal variation of the gingival temperature, which had a trend to a high interindividual correlation. The absolute individual differences was upto 2 degrees C. The lower jaw had a higher temperature than the upper jaw. The temperature of the right and left sides of the jaw differed from each other. The calculation of a standard temperature is only useful, when it is related to the individual sublingual temperature.  相似文献   
30.
Metastasen     
Ohne Zusammenfassung  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号